Cell BiologyCellPeer-reviewed
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential
László Radnai, Erica J. Young, Carlos Massayuki Kikuti…·Courtney A. Miller
This paper develops a selective non-muscle myosin II inhibitor, MT-228, with high brain penetration and efficacy in preclinical models, offering therapeutic potential for diseases like stimulant use disorder.